Switching From Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.04.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Public Health Measures to Reduce Smoking Prevalence in the UK: How Many Lives Could Be Saved?

Tobacco Control
EnvironmentalPublic HealthHealthOccupational Health
2005English

Donation of Medicines to Developing Countries

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
1994English

Rational Use of Medicines in Developing Countries

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2017English

How Simple Could Life Be?

Angewandte Chemie - International Edition
CatalysisChemistry
2017English

Consumer Choice Between Common Generic and Brand Medicines in a Country With a Small Generic Market

Journal of managed care & specialty pharmacy
Health PolicyPharmacyPharmaceutical Science
2015English

How Much Redistribution Should There Be?

Yale Law Journal
Law
2003English

How Much Can Really Be Saved by Rolling Back SCHIP? The Net Cost of Public Health Insurance for Children

Inquiry
Health Policy
2005English

Improving Access to Medicines for Neglected Tropical Diseases in Developing Countries: Lessons From Three Emerging Economies

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2012English

How Could You Use the Ergonomics ‘Knowhow’ Transfer Management to Enhance Human Working for Sustainable Improvements in Industrially Developing Countries?

Work
MedicineEnvironmentalPublic HealthRehabilitationOccupational Health
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy